DSIP / BPC-157 / CJC-1295.
A nighttime recovery protocol combining sleep depth, tissue repair, and growth hormone support.
1 mg / 2 mg / 2 mg per mL · single-vial injectablePricing is shown after your free assessment, before you commit.
Free to start. No card required.
Reviewed by Lumora clinical team (Licensed provider network)Mixed evidenceSource: Client-approved product catalog; provider review required
Evidence, regulatory status, and fit vary by medication, formulation, route, and individual history.
Is this for you?
This is for you if
- Patients with disrupted sleep and recovery issues
- Patients recovering from injury, training, or surgery
- Patients with burnout, overtraining, or chronic stress
- Patients wanting to consolidate multiple nighttime peptides into one injection
This isn't for you if
Components are investigational and subject to ongoing FDA review. Not appropriate during pregnancy, breastfeeding, or with active malignancy. Disclose sleep medications and psychiatric history before starting.
DSIP / BPC-157 / CJC-1295
This three-peptide combination is designed for once-nightly use during the body's natural overnight repair window. It pairs DSIP (sleep architecture), BPC-157 (tissue repair), and CJC-1295 (growth hormone support) so all three pathways activate during sleep.
Mechanism and fit.
DSIP supports deeper, more restorative slow-wave sleep — the stage during which most physical repair occurs. BPC-157 accelerates tissue repair and reduces inflammation overnight. CJC-1295 keeps the upstream GH-release signal active so nocturnal growth hormone pulses are restored. Together, the protocol transforms sleep into a true regenerative window rather than just rest.
Who this is typically for.
- Patients with disrupted sleep and recovery issues
- Patients recovering from injury, training, or surgery
- Patients with burnout, overtraining, or chronic stress
- Patients wanting to consolidate multiple nighttime peptides into one injection
What patients
most often ask.
Will this make me feel sedated in the morning?
DSIP isn't a sedative — it supports natural sleep architecture rather than knocking you out. Most patients report waking more refreshed, not groggier.
Why combine all three?
Sleep, repair, and growth hormone are tightly linked. Restoring sleep depth without GH support, or GH support without sleep depth, addresses only part of the recovery problem. The combination is designed to repair all three at once.
Who this is typically for.
These are common fit patterns from the approved catalog. Your provider determines whether treatment is appropriate.
- <ul><li>Patients with disrupted sleep and recovery issues</li><li>Patients recovering from injury, training, or surgery</li><li>Patients with burnout, overtraining, or chronic stress</li><li>Patients wanting to consolidate multiple nighttime peptides into one injection</li></ul>
How this option
is evaluated.
The plan is provider-determined after reviewing your assessment and safety factors.
- DosingOnce nightly subcutaneously, 30–60 minutes before bed; typically 5 nights on / 2 nights off.
- Typical durationInitial cycle 6–8 weeks.
- Safety and eligibilityYour provider reviews contraindications, medication interactions, goals, and safety factors before prescribing.
- A licensed provider reviews your assessment before any treatment is recommended.
- You see full pricing - visit fees, medication, labs, follow-up - before you commit.
- Your plan can be adjusted, paused, or stopped based on response and safety. Your clinician is reachable - not a chatbot.
- Compounded medications are not FDA-approved and are dispensed only when prescribed by a licensed provider.
Start with
provider review.
If you are considering DSIP / BPC-157 / CJC-1295, the first step is a free assessment. A provider determines whether it fits your goals and medical history.
A provider determines whether treatment is clinically appropriate.